These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30799252)

  • 1. Early transmission and case fatality of Ebola virus at the index site of the 2013-16 west African Ebola outbreak: a cross-sectional seroprevalence survey.
    Timothy JWS; Hall Y; Akoi-Boré J; Diallo B; Tipton TRW; Bower H; Strecker T; Glynn JR; Carroll MW
    Lancet Infect Dis; 2019 Apr; 19(4):429-438. PubMed ID: 30799252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus.
    Glynn JR; Bower H; Johnson S; Houlihan CF; Montesano C; Scott JT; Semple MG; Bangura MS; Kamara AJ; Kamara O; Mansaray SH; Sesay D; Turay C; Dicks S; Wadoum REG; Colizzi V; Checchi F; Samuel D; Tedder RS
    Lancet Infect Dis; 2017 Jun; 17(6):645-653. PubMed ID: 28256310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study.
    Diallo MSK; Rabilloud M; Ayouba A; Touré A; Thaurignac G; Keita AK; Butel C; Kpamou C; Barry TA; Sall MD; Camara I; Leroy S; Msellati P; Ecochard R; Peeters M; Sow MS; Delaporte E; Etard JF;
    Lancet Infect Dis; 2019 Mar; 19(3):308-316. PubMed ID: 30765243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The factors affecting household transmission dynamics and community compliance with Ebola control measures: a mixed-methods study in a rural village in Sierra Leone.
    Caleo G; Duncombe J; Jephcott F; Lokuge K; Mills C; Looijen E; Theoharaki F; Kremer R; Kleijer K; Squire J; Lamin M; Stringer B; Weiss HA; Culli D; Di Tanna GL; Greig J
    BMC Public Health; 2018 Feb; 18(1):248. PubMed ID: 29439682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study.
    Thom R; Tipton T; Strecker T; Hall Y; Akoi Bore J; Maes P; Raymond Koundouno F; Fehling SK; Krähling V; Steeds K; Varghese A; Bailey G; Matheson M; Kouyate S; Coné M; Moussa Keita B; Kouyate S; Richard Ablam A; Laenen L; Vergote V; Guiver M; Timothy J; Atkinson B; Ottowell L; Richards KS; Bosworth A; Longet S; Mellors J; Pannetier D; Duraffour S; Muñoz-Fontela C; Sow O; Koivogui L; Newman E; Becker S; Sprecher A; Raoul H; Hiscox J; Henao-Restrepo AM; Sakoba K; Magassouba N; Günther S; Kader Konde M; Carroll MW
    Lancet Infect Dis; 2021 Apr; 21(4):507-516. PubMed ID: 33065039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreak of Ebola virus disease in the Democratic Republic of the Congo, April-May, 2018: an epidemiological study.
    Ebola Outbreak Epidemiology Team
    Lancet; 2018 Jul; 392(10143):213-221. PubMed ID: 30047375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deaths, late deaths, and role of infecting dose in Ebola virus disease in Sierra Leone: retrospective cohort study.
    Bower H; Smout E; Bangura MS; Kamara O; Turay C; Johnson S; Oza S; Checchi F; Glynn JR
    BMJ; 2016 May; 353():i2403. PubMed ID: 27188404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals.
    Herrera BB; Hamel DJ; Oshun P; Akinsola R; Akanmu AS; Chang CA; Eromon P; Folarin O; Adeyemi KT; Happi CT; Lu Y; Ogunsola F; Kanki PJ
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006530. PubMed ID: 29795572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally Symptomatic Infection in an Ebola 'Hotspot': A Cross-Sectional Serosurvey.
    Richardson ET; Kelly JD; Barrie MB; Mesman AW; Karku S; Quiwa K; Marsh RH; Koedoyoma S; Daboh F; Barron KP; Grady M; Tucker E; Dierberg KL; Rutherford GW; Barry M; Jones JH; Murray MB; Farmer PE
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005087. PubMed ID: 27846221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014-2016: A cross-sectional study.
    Houlihan CF; McGowan CR; Dicks S; Baguelin M; Moore DAJ; Mabey D; Roberts CH; Kumar A; Samuel D; Tedder R; Glynn JR
    PLoS Med; 2017 May; 14(5):e1002300. PubMed ID: 28510604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.
    Bratcher A; Hoff NA; Doshi RH; Gadoth A; Halbrook M; Mukadi P; Musene K; Ilunga-Kebela B; Spencer D; Bramble MS; McIlwan D; Kelly JD; Mukadi D; Kingebeni PM; Ahuka S; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Rimoin AW
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009566. PubMed ID: 34383755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the frequency of asymptomatic Ebola virus infection.
    Mbala P; Baguelin M; Ngay I; Rosello A; Mulembakani P; Demiris N; Edmunds WJ; Muyembe JJ
    Philos Trans R Soc Lond B Biol Sci; 2017 May; 372(1721):. PubMed ID: 28396474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebola Virus-Specific Neutralizing Antibody Persists at High Levels in Survivors 2 Years After Resolution of Disease in a Sierra Leonean Cohort.
    Bond NG; Shore KR; Engel EJ; Coonan EE; Al-Hasan F; Gbakie MA; Kamara FK; Kanneh L; Momoh M; Kanneh IM; Sandi JD; Elliott D; Ficenec SC; Smira AR; Fischer WA; Wohl DA; Robinson JE; Shaffer JG; Garry RF; Samuels RJ; Grant DS; Schieffelin JS
    J Infect Dis; 2024 Oct; 230(4):e929-e937. PubMed ID: 38801652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of IgG antibodies to Ebola virus in the Efé pygmy population in the Watsa region, Democratic Republic of the Congo.
    Mulangu S; Borchert M; Paweska J; Tshomba A; Afounde A; Kulidri A; Swanepoel R; Muyembe-Tamfum JJ; Van der Stuyft P
    BMC Infect Dis; 2016 Jun; 16():263. PubMed ID: 27286990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profile and containment of the Ebola virus disease outbreak in two large West African cities, Nigeria, July-September 2014.
    Ohuabunwo C; Ameh C; Oduyebo O; Ahumibe A; Mutiu B; Olayinka A; Gbadamosi W; Garcia E; Nanclares C; Famiyesin W; Mohammed A; Nguku P; Koko RI; Obasanya J; Adebayo D; Gbadegesin Y; Idigbe O; Oguntimehin O; Nyanti S; Nzuki C; Abdus-Salam I; Adeyemi J; Onyekwere N; Musa E; Brett-Major D; Shuaib F; Nasidi A
    Int J Infect Dis; 2016 Dec; 53():23-29. PubMed ID: 27575939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebola virus disease in children during the 2014-2015 epidemic in Guinea: a nationwide cohort study.
    Chérif MS; Koonrungsesomboon N; Kassé D; Cissé SD; Diallo SB; Chérif F; Camara F; Koné A; Avenido EF; Diakité M; Diallo MP; Le Gall E; Cissé M; Karbwang J; Hirayama K
    Eur J Pediatr; 2017 Jun; 176(6):791-796. PubMed ID: 28444452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2020 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo: a retrospective genomic characterisation.
    Kinganda-Lusamaki E; Whitmer S; Lokilo-Lofiko E; Amuri-Aziza A; Muyembe-Mawete F; Makangara-Cigolo JC; Makaya G; Mbuyi F; Whitesell A; Kallay R; Choi M; Pratt C; Mukadi-Bamuleka D; Kavunga-Membo H; Matondo-Kuamfumu M; Mambu-Mbika F; Ekila-Ifinji R; Shoemaker T; Stewart M; Eng J; Rajan A; Soke GN; Fonjungo PN; Otshudiema JO; Folefack GLT; Pukuta-Simbu E; Talundzic E; Shedroff E; Bokete JL; Legand A; Formenty P; Mores CN; Porzucek AJ; Tritsch SR; Kombe J; Tshapenda G; Mulangu F; Ayouba A; Delaporte E; Peeters M; Wiley MR; Montgomery JM; Klena JD; Muyembe-Tamfum JJ; Ahuka-Mundeke S; Mbala-Kingebeni P
    Lancet Microbe; 2024 Feb; 5(2):e109-e118. PubMed ID: 38278165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomy of a Hotspot: Chain and Seroepidemiology of Ebola Virus Transmission, Sukudu, Sierra Leone, 2015-16.
    Kelly JD; Barrie MB; Mesman AW; Karku S; Quiwa K; Drasher M; Schlough GW; Dierberg K; Koedoyoma S; Lindan CP; Jones JH; Chamie G; Worden L; Greenhouse B; Weiser SD; Porco TC; Rutherford GW; Richardson ET
    J Infect Dis; 2018 Mar; 217(8):1214-1221. PubMed ID: 29325149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda.
    Nyakarahuka L; Schafer IJ; Balinandi S; Mulei S; Tumusiime A; Kyondo J; Knust B; Lutwama J; Rollin P; Nichol S; Shoemaker T
    BMC Infect Dis; 2020 Jul; 20(1):461. PubMed ID: 32611400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study.
    Etard JF; Sow MS; Leroy S; Touré A; Taverne B; Keita AK; Msellati P; Magassouba N; Baize S; Raoul H; Izard S; Kpamou C; March L; Savane I; Barry M; Delaporte E;
    Lancet Infect Dis; 2017 May; 17(5):545-552. PubMed ID: 28094208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.